ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
알프롤릭스 시장 규모는 향후 몇 년간 급속한 성장을 기록할 것으로 예상됩니다. 예측 기간 동안의 성장은 개인 맞춤형 의학, 반감기 연장 요인 치료법의 채택 증가, 치료 순응도 및 삶의 질 개선에 대한 관심 증가, 신흥 시장의 의료 인프라 확대, 출혈 장애에 대한 인식 제고에 기인할 수 있습니다. 예측 기간 동안의 주요 트렌드로는 제약 회사와 의료 서비스 제공자 간의 협력, 제품 혁신, 응고 인자 치료법의 발전, 반감기 연장 치료법을 통한 환자 치료 개선 등이 있습니다.
B형 혈우병의 유병률이 증가함에 따라 향후 몇 년 동안 알프로릭스 시장이 확대될 것으로 예상됩니다. 크리스마스 병이라고도 알려진 B형 혈우병은 응고 인자 IX의 결핍 또는 부재로 인해 발생하는 희귀 유전성 출혈 장애입니다. B형 혈우병의 발생률 증가 는 진단 기술의 개선, 인식 및 보고의 증가, 조기 발견을 가능하게 하는 의료 시스템의 개선, 치료 옵션의 발전으로 인한 혈우병 환자의 기대수명 연장 등에 기인합니다. 장기 작용형 재조합 응고 인자 IX인 알프로릭스는 반감기가 길어 보호 효과가 오래 지속되어 출혈 횟수와 주입 빈도를 줄여 B형 혈우병 환자에게 유익하며, 궁극적으로 환자의 삶의 질을 개선합니다. 예를들어 2023년 10월에 세계 혈우병 연맹(WFH)이 발표한 보고서에 따르면 2022년 현재 세계 25만 7,146명의 혈우병 환자가 확인되었으며, 그 중 4만 2,203명이 B형 혈우병환자임이 밝혀졌습니다.
알프롤릭스 시장은 B형 혈우병 치료 분야의 미충족 의료 수요를 충족시키기 위한 혁신적인 치료법에 대한 집중으로 최근 몇 년간 눈에 띄는 진전을 이뤘습니다. 유망한 개발 중 하나는 아데노 관련 바이러스(AAV) 벡터를 사용하여 FIX 유전자의 기능적 사본을 전달하는 인자 IX 유전자 치료입니다. 이 접근법은 장기적인 응고 인자 생산을 제공하고, 출혈 증상을 줄이며, B형 혈우병에 대한 일회성 치료를 제공할 수 있는 것을 목표로 합니다. 예를 들어, 2024년 4월, Pfizer Inc.는 B형 혈우병 치료를 위해 설계된 유전자 치료제인 Beqveztm (fidanacogene elaparvovec)에 대해 미국 FDA의 승인을 받았습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여 경로(ROA)
작용 기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 알프롤릭스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 알프롤릭스 시장 : 성장률 분석
세계의 알프롤릭스 시장 실적 : 규모와 성장(2019-2024년)
세계의 알프롤릭스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 알프롤릭스 : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 알프롤릭스 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
재조합 응고 인자 IX
혈장 유래 응고 인자 IX
세계의 알프롤릭스 시장 : 배합별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
주사액
재구성 분말
세계의 알프롤릭스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
B형 혈우병 치료
예방
수술
세계의 알프롤릭스 시장 : 유통별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
온라인 약국
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 알프롤릭스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 알프롤릭스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
알프롤릭스 시장 : 경쟁 구도
알프롤릭스 시장 : 기업 프로파일
Sanofi
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
알프롤릭스 시장(2029년) : 새로운 기회를 제공하는 국가
알프롤릭스 시장(2029년) : 새로운 기회를 제공하는 부문
알프롤릭스 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Alprolix is a recombinant coagulation factor IX Fc fusion protein designed to treat and prevent bleeding episodes in individuals with hemophilia B. It works by substituting the missing factor IX, promoting proper blood clotting, and has an extended half-life, which minimizes the need for frequent infusions to maintain effective treatment.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The alprolix market primarily consists of recombinant coagulation factor IX and plasma-derived coagulation factor IX. Recombinant factor IX is a bioengineered protein used to replace the deficient or dysfunctional factor IX in hemophilia B patients, helping to prevent excessive bleeding and support normal clotting. These products are available in different formulations, including injectable solutions and reconstitution powders. They are applied in treatments for hemophilia B, prophylaxis, and surgeries and are distributed through hospitals, specialty clinics, and online pharmacies.
The alprolix market research report is one of a series of new reports from The Business Research Company that provides alprolix market statistics, including alprolix industry global market size, regional shares, competitors with a alprolix market share, detailed alprolix market segments, market trends, and opportunities, and any further data you may need to thrive in the alprolix industry. This alprolix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alprolix market size is expected to see rapid growth in the next few years. It will grow to $1,911.2 million in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to personalized medicine, increasing adoption of extended half-life factor therapies, greater focus on improving treatment adherence and quality of life, expanding healthcare infrastructure in emerging markets, rising awareness about bleeding disorders. Major trends in the forecast period include collaborations between pharmaceutical companies and healthcare providers, product innovations, advancements in clotting factor therapies, improvements in patient care through extended half-life therapies.
The growing prevalence of hemophilia B is expected to drive the expansion of the alprolix market in the coming years. Hemophilia B, also known as Christmas disease, is a rare inherited bleeding disorder caused by a deficiency or absence of clotting factor IX. The rising incidence of hemophilia B is largely attributed to improvements in diagnostic techniques, increased awareness and reporting, better healthcare systems that enable earlier detection, and the longer life expectancy of individuals with hemophilia due to advancements in treatment options. Alprolix, a long-acting recombinant clotting factor IX, is beneficial for patients with hemophilia B as it reduces bleeding episodes and the frequency of infusions by offering extended protection through its prolonged half-life, ultimately improving patients' quality of life. For example, in October 2023, a report from the World Federation of Hemophilia (WFH) revealed that, as of 2022, there were 257,146 identified hemophilia patients worldwide, including 42,203 individuals with hemophilia B. As such, the increasing prevalence of hemophilia B is a key factor driving the alprolix market.
The alprolix market has seen notable progress in recent years, fueled by a focus on innovative therapies to address unmet medical needs in hemophilia B treatment. One of the promising developments is Factor IX gene therapy, which involves delivering a functional copy of the FIX gene using adeno-associated virus (AAV) vectors. This approach aims to provide long-term clotting factor production, reduce bleeding episodes, and potentially offer a one-time treatment for hemophilia B. For instance, in April 2024, Pfizer Inc. received approval from the U.S. FDA for Beqveztm (fidanacogene elaparvovec), a gene therapy designed to treat hemophilia B. This approval represents a significant breakthrough in hemophilia treatment, offering the potential for a one-time therapy that could eliminate or reduce the need for routine clotting factor infusions. The therapy works by delivering a functional copy of the recombinant clotting factor IX gene, which provides sustained levels of factor IX and helps prevent bleeding episodes. Clinical trials have demonstrated durable efficacy and a favorable safety profile for patients with severe or moderately severe hemophilia B.
In August 2024, Bora Pharmaceuticals, a Taiwan-based pharmaceutical company, acquired Emergent BioSolutions for an undisclosed sum. This acquisition will allow Bora Pharma to expand its capabilities in the biotechnology and pharmaceutical sectors, particularly by enhancing its contract development and manufacturing services (CDMO) portfolio. Emergent BioSolutions, a U.S.-based company, is known for offering recombinant coagulation factor IX-based treatments.
Key player operating in the alprolix market is Sanofi
North America was the largest region in the alprolix market in 2024. The regions covered in alprolix report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the alprolix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The alprolix market consists of sales of alprolix 250IU and alprolix 500 IU. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Alprolix Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on alprolix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for alprolix ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alprolix market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Recombinant Coagulation Factor IX; Plasma-Derived Coagulation Factor IX
2) By Formulation: Injectable Solution; Powder For Reconstitution
3) By Application: Hemophilia B Treatment; Prophylaxis; Surgery
4) By Distribution: Hospitals; Specialty Clinics; Online Pharmacies
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Alprolix Market Characteristics
3. Alprolix Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Alprolix Market Trends And Strategies
5. Alprolix Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Alprolix Growth Analysis And Strategic Analysis Framework
6.1. Global Alprolix PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Alprolix Market Growth Rate Analysis
6.4. Global Alprolix Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Alprolix Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Alprolix Total Addressable Market (TAM)
7. Global Alprolix Market Pricing Analysis & Forecasts
8. Alprolix Market Segmentation
8.1. Global Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Coagulation Factor IX
Plasma-Derived Coagulation Factor IX
8.2. Global Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Solution
Powder For Reconstitution
8.3. Global Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hemophilia B Treatment
Prophylaxis
Surgery
8.4. Global Alprolix Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinis
Online Pharmacies
9. Global Alprolix Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Alprolix Market Regional And Country Analysis
10.1. Global Alprolix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Alprolix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Alprolix Market
11.1. Asia-Pacific Alprolix Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Alprolix Market
12.1. China Alprolix Market Overview
12.2. China Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Alprolix Market
13.1. India Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Alprolix Market
14.1. Japan Alprolix Market Overview
14.2. Japan Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Alprolix Market
15.1. Australia Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Alprolix Market
16.1. South Korea Alprolix Market Overview
16.2. South Korea Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Alprolix Market
17.1. Western Europe Alprolix Market Overview
17.2. Western Europe Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Alprolix Market
18.1. UK Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Alprolix Market
19.1. Germany Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Alprolix Market
20.1. France Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Alprolix Market
21.1. Eastern Europe Alprolix Market Overview
21.2. Eastern Europe Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Alprolix Market
22.1. North America Alprolix Market Overview
22.2. North America Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Alprolix Market
23.1. USA Alprolix Market Overview
23.2. USA Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Alprolix Market
24.1. Canada Alprolix Market Overview
24.2. Canada Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Alprolix Market
25.1. South America Alprolix Market Overview
25.2. South America Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Alprolix Market
26.1. Middle East Alprolix Market Overview
26.2. Middle East Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Alprolix Market
27.1. Africa Alprolix Market Overview
27.2. Africa Alprolix Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Alprolix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Alprolix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Alprolix Market Competitive Landscape And Company Profiles
28.1. Alprolix Market Competitive Landscape
28.2. Alprolix Market Company Profiles
28.2.1. Sanofi Overview, Products and Services, Strategy and Financial Analysis
29. Global Alprolix Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Alprolix Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Alprolix Market
32. Recent Developments In The Alprolix Market
33. Alprolix Market High Potential Countries, Segments and Strategies
33.1 Alprolix Market In 2029 - Countries Offering Most New Opportunities
33.2 Alprolix Market In 2029 - Segments Offering Most New Opportunities
